Funder: National Institutes of Health (NIH)
Due Dates: January 27, 2026 (forecasted)
Funding Amounts: Estimated total program funding: $3,000,000 | Expected number of awards: 1 | Cooperative Agreement
Summary: Establishes a Center to train and support researchers in developing new pharmacotherapeutics for substance use disorder (SUD), including education, outreach, and preclinical support.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.